Brief: Theravance Biopharma CFO Andrew Hindman Steps Down

Theravance Biopharma

12/12/2022 13:44

Dec 12 (Reuters) - Theravance Biopharma Inc  TBPH.O :
    * THERAVANCE BIOPHARMA INC- ANDREW A. HINDMAN, SENIOR VICE
PRESIDENT AND CHIEF FINANCIAL OFFICER, WILL TRANSITION FROM THE
COMPANY ON DECEMBER 31, 2022
    * THERAVANCE BIOPHARMA INC- APPOINTED AZIZ SAWAF, CFA AS THE
COMPANY’S CHIEF FINANCIAL OFFICER, EFFECTIVE IMMEDIATELY

Source text for Eikon:  ID: 
Further company coverage:  TBPH.O 
 ((Reuters.Briefs@thomsonreuters.com;))